Asuka Pharmaceutical Holdings has resolved to appoint EY Shin-Nihon LLC as its new accounting auditor at the Shareholders’ Meeting scheduled for June 24, 2026. The retiring auditor is Kiyo Audit Corporation. This change is part of a reassessment of the audit system and efforts to adapt to global expansion.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4886","jir_company_name":"Asuka Pharmaceutical Holdings Inc.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-05-25","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4886-20260525-03.pdf","jir_short_summary":"Asuka Pharmaceutical Holdings has resolved to appoint EY Shin-Nihon LLC as its new accounting auditor at the Shareholders' Meeting scheduled for June 24, 2026. The retiring auditor is Kiyo Audit Corporation. This change is part of a reassessment of the audit system and efforts to adapt to global expansion.","jir_summary":"### Regarding the Change of Certified Public Accountant\nThe Company has resolved to appoint EY Shin-Nihon LLC as its new accounting auditor at the 5th Annual General Shareholders' Meeting scheduled for June 24, 2026. Accordingly, the retiring auditor is Kiyo Audit Corporation, as part of reviewing the audit system and establishing a structure to support global expansion. The reason for selecting the new audit firm is its suitability from the perspective of new viewpoints, expertise, independence, and quality control systems.\n\n### Impact on Shareholders and Future Outlook\nThis change of audit firm aims to improve audit quality and support global expansion. It is expected to lead to a more robust financial audit framework for shareholders and investors. The transition from the retiring to the new audit firm is scheduled for June 24, 2026. This is anticipated to enhance the reliability of the Company's financial reporting and further promote its global business development.","jir_financial_highlights":"","jir_category":"","jir_hashtags":"#AsukaPharmaceutical, #IRRelated, #JapaneseStocks","jir_key_figures":"Scheduled Change Date: June 24, 2026\nRetiring Certified Public Accountant: Kiyo Audit Corporation\nNewly Appointed Certified Public Accountant: EY Shin-Nihon LLC","jir_meta_title":"\u3010Asuka Pharmaceutical\u3011Notice of Certified Public Accountant Change | May 2026","jir_meta_description":"Asuka Pharmaceutical Holdings will appoint a new accounting auditor at the June 2026 Shareholders' Meeting. It aims to refresh its audit system and support global expansion.","jir_og_title":"\u3010Asuka Pharmaceutical\u3011Notice of Certified Public Accountant Change | May 2026","jir_og_description":"Asuka Pharmaceutical will change its audit firm in June 2026 to enhance audit quality and support global development.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17164,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-54415","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n